Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Lingying Wu"'
Autor:
Hui Tian, Xuan Wang, Bin Lian, Lu Si, Min Gao, Hong Zheng, Zhihong Chi, Yan Kong, Lili Mao, Xue Bai, Bixia Tang, Xieqiao Yan, Siming Li, Li Zhou, Jie Dai, Yangchun Sun, Lingying Wu, Jun Guo, Chuanliang Cui
Publikováno v:
Frontiers in Surgery, Vol 8 (2022)
Objective: To evaluate the effectiveness of radical resection compared with non-radical resection for vaginal or cervical melanoma.Methods: We retrospectively analysed the clinical data of post-operative patients with primary lower genital tract mela
Externí odkaz:
https://doaj.org/article/89fbe4eb2d7948f998433add28f0bb47
Autor:
Yu Zhang, Ying Jin, Lingya Pan, Rong Li, Jing Zuo, Yu Gu, Ce Bian, Ying Yue, Chun-yan Wang, Meng Qin, Lingying Wu, Yu-mei Wu, Ning Li, Ke-qiang Zhang
Publikováno v:
Frontiers in Oncology
Frontiers in Oncology, Vol 10 (2021)
Frontiers in Oncology, Vol 10 (2021)
ObjectiveThis study assessed the predictive value of preoperative computed tomography (CT) scans and clinical factors for optimal debulking surgery (ODS) in patients with advanced ovarian cancer (AOC).MethodsPatients with AOC in International Federat
Publikováno v:
International Journal of Gynecologic Cancer. 28:713-720
ObjectiveThis study aimed to investigate the role of neoadjuvant bleomycin, etoposide, and cisplatin (BEP) regimen in patients with extensively advanced yolk sac tumors (YSTs).MethodsBetween July 1982 and December 2015, a total of 58 patients with YS
Publikováno v:
Oncotarget
// Guangwen Yuan 1 , Lingying Wu 1 , Bin Li 1 and Jusheng An 1 1 Department of Gynecologic Oncology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, 100021, China Correspondence to:
Publikováno v:
Cancer. 123:420-425
BACKGROUND Nanoparticle albumin-bound paclitaxel (nab-paclitaxel) and nedaplatin (NDP) are used for the treatment of patients with cervical cancer. However, to the authors’ knowledge, the use of this combination regimen among patients with advanced
Autor:
Jiaxin Yang, Zhenyu Zhang, Yang Xiang, Bin Ling, Lei Song, Lingying Wu, Fengzhi Feng, Dongyan Cao, Hengzi Sun, Keng Shen
Publikováno v:
Frontiers in Oncology, Vol 8 (2018)
Frontiers in Oncology
Frontiers in Oncology
Introduction: With the expansion of value-based medicine, we explore whether using type III hysterectomy to treat low-risk, early-stage cervical cancer constitutes overtreatment. In present study, we evaluate the midterm safety and postoperative qual
Publikováno v:
Molecular and Clinical Oncology. 4:245-248
The aim of this study was to investigate the clinical effect of bevacizumab (BEV) combined with chemotherapy in advanced or recurrent uterine sarcoma. The clinical data of 4 patients with advanced or recurrenct uterine sarcoma, who received treatment
Publikováno v:
World Journal of Surgical Oncology
Background The aim of the study is to investigate the clinical features, treatments, and prognosis of stage 1 embryonal rhabdomyosarcoma of the female genital tract. Methods A retrospective analysis was performed on nine cases of stage 1 embryonal rh
Publikováno v:
Journal of Clinical Oncology. 33:e16591-e16591
e16591 Background: Bulky local tumor ( ≥ 4cm) is a poor prognostic factor for early stage cervical cancer patients. Most of the locally advanced cervical cancer patients need postoperative radiothe...
Publikováno v:
World Journal of Surgical Oncology; 2/7/2017, Vol. 15, p1-5, 5p